Thomas Joseph Sullivan Net Worth

Mr. Thomas Joseph Sullivan biography

Thomas Joseph Sullivan is the Pres, CEO & Director at Natus Medical Inc.

What is the salary of Mr Sullivan?

As the Pres y CEO & Director of Natus Medical Inc, the total compensation of Mr Sullivan at Natus Medical Inc is $95,000. There are 12 executives at Natus Medical Inc getting paid more, with Jonathan Kennedy having the highest compensation of $3,335,550.

How old is Mr Sullivan?

Mr Sullivan is 57, he's been the Pres y CEO & Director of Natus Medical Inc since . There are 4 older and 10 younger executives at Natus Medical Inc. The oldest executive at Natus Medical Inc is Kenneth Ludlum, 66, who is the Independent Director.

What's Mr Sullivan's mailing address?

Thomas's mailing address filed with the SEC is C/O NATUS MEDICAL INCORPORATED, 3150 PLEASANT VIEW ROAD, MIDDLETON, WI, 53562.

Insiders trading at Natus Medical Inc

Over the last 5 years, insiders at Natus Medical Inc have traded over $3,793,396 worth of Natus Medical Inc stock. The most active insiders traders include Dong Chune Christopher Chung, Joshua Levine y Jonathan Kennedy. On average, Natus Medical Inc executives and independent directors trade stock every 70 days with the average trade being worth of $543,972. The most recent stock trade was executed by Dong Chune Christopher Chung on 9 December 2021, trading 11,787 units of NTUS stock currently worth $243,755.

What does Natus Medical Inc do?

Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.

Natus Medical Inc executives and stock owners

Natus Medical Inc executives and other stock owners filed with the SEC include:

• Jonathan Kennedy,
  President, Chief Executive Officer, Director
• B. Drew Davies,
  Chief Financial Officer, Executive Vice President
• Austin Noll,
  Executive Vice President and Chief Commercial Officer
• D. Christopher Chung,
  Vice President - Quality, Regulatory Affairs and Chief Medical Officer
• Benjamin Drew Davies,
  Exec. VP & CFO
• Austin F. Noll III,
  Exec. VP & Chief Commercial Officer
• Dr. D. Christopher Chung M.D.,
  VP of Quality, Regulatory Affairs & Chief Medical Officer
• Dr. D. Christopher Chung,
  VP of Quality, Regulatory Affairs & Chief Medical Officer
• Barbara Paul,
  Independent Chairman of the Board
• Kenneth Ludlum,
  Independent Director
• Lisa Heine,
  Independent Director
• Joshua Levine,
  Independent Director
• Thomas Joseph Sullivan,
  Pres, CEO & Director
• Alice Schroeder,
  Independent Director
• Thomas Sullivan,
  Independent Director
• Ilan Daskal,
  Independent Director
• William Hill,
  General Counsel
• Sean Langan,
  Vice President of Global Operations
• Lisa Paul,
  Vice President and Chief People Officer
• Douglas Balog,
  VP, Gen. Counsel & Sec.
• Lisa Paul,
  Chief People Officer & VP
• Ivan Pandiyan,
  VP of Global R&D
• Seán Langan,
  VP Global Operations
• Eric Guerin,
  Director
• Bryant M Moore,
  Director